1. Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 Agonists.
- Author
-
Thomson CG, Boss K, Calhoun A, Fridrich C, Gardinier KM, Hall EC, Jendza K, Kirman L, Labbé-Giguere N, Laumen K, Qian M, Sanyal S, Shultz MD, Snajdrova R, Tan K, Wang KY, Yang F, Gao F, Hong T, Dale E, Kuzmiski B, Ortuno D, and Palacios DS
- Abstract
We have developed a chiral route toward the synthesis of muscarinic M4 agonists that was enabled by the biocatalytic synthesis of the key spirocyclic diamine building blocks 10 and 12 . Using these bifunctional compounds we were able to optimize a synthetic sequence toward a collection of advanced intermediates for further elaboration. These advanced intermediates were then used as starting points for early medicinal chemistry and the identification of selective M1/M4 agonists., Competing Interests: The authors declare the following competing financial interest(s): At the time of the work, all authors were employees of Novartis AG, which has filed patents on selective M4 agonists for the treatment of psychosis., (© 2023 American Chemical Society.)
- Published
- 2023
- Full Text
- View/download PDF